Falls Among the Older Patients Treated for Cancer in Normandy's Outclinics: Screening and Prevention
NCT ID: NCT06504628
Last Updated: 2025-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
328 participants
OBSERVATIONAL
2024-09-16
2025-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study consists of a cross-sectional survey conducted during a week dedicated to patient safety (September 16-20, 2024), to identify the prevalence of patients at high risk for falling, requiring enhanced care. The relation between high risk for falling and social and oncological characteristics will be studied. A 3-month telephone follow-up will identify any obstacles to implementing the recommendations in this high-risk group.
This multicenter cross-sectional prospective study is exploratory.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Falls in Older Inpatients Hospitalized at Angers University Hospital
NCT02120209
Optimizing Fall-risk Prediction in Older Adults With Cancer
NCT02912273
Follow-up of Elderly Subjects With Falls Recruited in the Geriatric Departments of Several French Hospitals
NCT05281835
Falls Risk Questionnaire in Older Adults With Cancer
NCT02204137
Falls Prevention in Acute Care Hospital
NCT01054287
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
low risk for fall subgroup
according to Manuel Montero-Odasso M, Nathalie van der Velde, Finbarr C Martin, Mirko Petrovic, Maw Pin Tan, Jesper Ryg, et al. World guidelines for falls prevention and management for older adults: a global initiative. Age and Ageing, Volume 51, Issue 9, September 2022
screening risk for falling and identifiy the risk level low-intermediate-high
3 key questions: Any posiitve answer to a) Has fallen in the past year? b) Feels unsteady when standing or walking? or c) Worries about falling? prompts to "fall severity" step.
if "no" at the three questions= low level of fall-risk Fall severity: fall with injuires, laying on the ground with no capacity to get up, or a visit to emergency room, or loss of conscienciousness/suspected syncope. or Frailty (Clinical Frailty Scale)= if positive, high risk otherwise, 4 meter-walk test: if =\<0.8m/sec= intermediate risk if \>0.8m/sec=intermediate risk
intermediate risk for fall subgroup
according to Manuel Montero-Odasso M, Nathalie van der Velde, Finbarr C Martin, Mirko Petrovic, Maw Pin Tan, Jesper Ryg, et al. World guidelines for falls prevention and management for older adults: a global initiative. Age and Ageing, Volume 51, Issue 9, September 2022
screening risk for falling and identifiy the risk level low-intermediate-high
3 key questions: Any posiitve answer to a) Has fallen in the past year? b) Feels unsteady when standing or walking? or c) Worries about falling? prompts to "fall severity" step.
if "no" at the three questions= low level of fall-risk Fall severity: fall with injuires, laying on the ground with no capacity to get up, or a visit to emergency room, or loss of conscienciousness/suspected syncope. or Frailty (Clinical Frailty Scale)= if positive, high risk otherwise, 4 meter-walk test: if =\<0.8m/sec= intermediate risk if \>0.8m/sec=intermediate risk
high risk for fall subgroup
according to Manuel Montero-Odasso M, Nathalie van der Velde, Finbarr C Martin, Mirko Petrovic, Maw Pin Tan, Jesper Ryg, et al. World guidelines for falls prevention and management for older adults: a global initiative. Age and Ageing, Volume 51, Issue 9, September 2022.
Those patients will be contacted 3 mnths after inclusion for follow-up assessment
screening risk for falling and identifiy the risk level low-intermediate-high
3 key questions: Any posiitve answer to a) Has fallen in the past year? b) Feels unsteady when standing or walking? or c) Worries about falling? prompts to "fall severity" step.
if "no" at the three questions= low level of fall-risk Fall severity: fall with injuires, laying on the ground with no capacity to get up, or a visit to emergency room, or loss of conscienciousness/suspected syncope. or Frailty (Clinical Frailty Scale)= if positive, high risk otherwise, 4 meter-walk test: if =\<0.8m/sec= intermediate risk if \>0.8m/sec=intermediate risk
3 mnth-follow-up
patient's phone call, and data collected from electronic medical record
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
screening risk for falling and identifiy the risk level low-intermediate-high
3 key questions: Any posiitve answer to a) Has fallen in the past year? b) Feels unsteady when standing or walking? or c) Worries about falling? prompts to "fall severity" step.
if "no" at the three questions= low level of fall-risk Fall severity: fall with injuires, laying on the ground with no capacity to get up, or a visit to emergency room, or loss of conscienciousness/suspected syncope. or Frailty (Clinical Frailty Scale)= if positive, high risk otherwise, 4 meter-walk test: if =\<0.8m/sec= intermediate risk if \>0.8m/sec=intermediate risk
3 mnth-follow-up
patient's phone call, and data collected from electronic medical record
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing treatment for cancer or hematological malignancy (oral or injectable systemic treatment, radiotherapy)
* covered by health insurance
* having read the information document and no objection
* French-speaking
* Autonomous ( with occasional assistance with instrumental daily activities),
Exclusion Criteria
* unable to communicate
* dependent (requiring geriatric care)
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Caen UH
Caen, Normandy, France
Centre de radiothérapie de la Baie
Avranches, , France
Centre de radiothérapie Maurice Tubiana/Polyclinique Parc
Caen, , France
CLCC François Baclesse
Caen, , France
Centre Hospitalier Public du Cotentin
Cherbourg, , France
Centre Hospitalier Evreux-VErnon
Évreux, , France
Hôpital Privé de l Estuaire
Le Havre, , France
Centre Hospitalier Robert Bisson
Lisieux, , France
Becquerel Cancer CEnter
Rouen, , France
CHU de Rouen Charles Nicolle
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-A00979-38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.